Henry Schein, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HSIC research report →
Companywww.henryschein.com
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
- CEO
- Andrea Albertini
- IPO
- 1995
- Employees
- 25,000
- HQ
- Melville, NY, US
Price Chart
Valuation
- Market Cap
- $8.34B
- P/E
- 21.31
- P/S
- 0.62
- P/B
- 2.58
- EV/EBITDA
- 12.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 29.69%
- Op Margin
- 5.60%
- Net Margin
- 2.95%
- ROE
- 11.86%
- ROIC
- 6.24%
Growth & Income
- Revenue
- $13.18B · 4.03%
- Net Income
- $398.00M · 2.05%
- EPS
- $3.29 · 7.17%
- Op Income
- $758.00M
- FCF YoY
- -13.31%
Performance & Tape
- 52W High
- $89.29
- 52W Low
- $61.95
- 50D MA
- $74.42
- 200D MA
- $72.66
- Beta
- 0.82
- Avg Volume
- 1.48M
Get TickerSpark's AI analysis on HSIC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 11, 26 | DANIEL WILLIAM K | buy | 10,000 |
| Mar 19, 26 | Popeck Thomas C | sell | 1,355 |
| Mar 16, 26 | South Ronald N. | other | 5,216 |
| Mar 16, 26 | Sheehy Christine Zayac | other | 463 |
| Mar 16, 26 | Popeck Thomas C | other | 587 |
| Mar 16, 26 | MLOTEK MARK E | other | 5,928 |
| Mar 16, 26 | Ettinger Michael S | other | 1,300 |
| Mar 16, 26 | Ettinger Michael S | other | 4,214 |
| Mar 17, 26 | Ettinger Michael S | other | 1,000 |
| Mar 16, 26 | BERGMAN STANLEY M | other | 400 |
Our HSIC Coverage
We haven't published any research on HSIC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HSIC Report →